Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-25 @ 1:25 AM
NCT ID:
NCT00343993
Eligibility Criteria:
Inclusion Criteria:
* Meet the ALI/ARDS criteria
Exclusion Criteria:
* Age \> 85
* pH \< 7.35 or PaCO2 \>50mmHg
* Glasgow Coma Scale (GCS)\<11
* Airway or facial deformity
* Pneumothorax or pneumomediastinum
* Unable to spontaneously clear secretions from their airway
* Respiratory arrest
* Shock or hemodynamic instability (systolic blood pressure \<90 mmHg associated with decreased urinary output (\<20 mL.h-1) despite fluid repletion and use of vasoactive agents) of other causes
* Severe ventricular arrhythmia or active myocardial ischemia
* Severe organ dysfunction (including gastrointestinal hemorrhage, disseminated intravascular coagulation, hepatic and renal dysfunction, SOFA score\>1)
* End-stage patients who are expected to survive less than six months
* Severe abdominal distension
* Refuse to receive NPPV
* Unable to cooperate with the application of NPPV
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00343993
Study Brief:
Protocol Section:
NCT00343993